All In Biotech

Drug Trial Radar · NCT04406649

A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine

An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine

Last checked: Nov 19, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

482

Actual

Start

Sep 14, 2020

Primary completion

Jan 16, 2023

Study completion Jan 16, 2023

Sponsor

Lead sponsor
Satsuma Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
May 28, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study STS101-003 is a multi-center, multiple dose (PRN), open-label, 12-month study to evaluate the safety and tolerability of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.

Conditions

  • Migraine
  • Migraine With Aura
  • Migraine Without Aura

Interventions

  • DihydroergotamineDrug

    Dihydroergotamine is a semi-synthetic derivative of ergotamine tartrate.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Attacks With Sustained Freedom From Headache Pain 2-48 Hours (Modified Intent to Treat Population)Time frame: At Month 12 of Study Medication Dosing
  2. Percentage of Participants With Attacks With Sustained Freedom From Most Bothersome Symptom 2-48 Hours (Modified Intent to Treat Population)Time frame: At Month 12 of Study Drug Administration

Locations

44 sites in 1 country. Site status is shown where the registry gives one.

  • WR-PRI

    Encino, California

  • Collaborative Neuroscience

    Long Beach, California

  • WR-PRI

    Los Alamitos, California

  • Downtown LA Research

    Los Angeles, California

  • Clinical Research Institute

    Los Angeles, California

  • WR-PRI

    Newport Beach, California

  • Hillcrest Medical Research

    DeLand, Florida

  • MD Clinical

    Hallandale, Florida

  • Multi-Specialty Research Associates

    Lake City, Florida

  • ClinCloud

    Maitland, Florida

  • Biotech Pharmaceuticals

    Miami, Florida

  • Behavioral Clinical Research

    Miami Lakes, Florida

  • CNS Health Care - Orlando

    Orlando, Florida

  • Complete Health Research

    Ormond Beach, Florida

  • Infinity Clinical Research

    Sunrise, Florida

  • Santos Research Center, Corp

    Tampa, Florida

  • Palm Beach Research Center

    West Palm Beach, Florida

  • Clinical Research CF

    Winter Haven, Florida

  • Advanced Clinical Research

    Meridian, Idaho

  • Integrated Clinical Trial Services, Inc

    West Des Moines, Iowa

  • Delricht Research

    Prairieville, Louisiana

  • Medvadis Research at Boston PainCare Center

    Waltham, Massachusetts

  • Healthcare Research Network

    Hazelwood, Missouri

  • Clinvest Research

    Springfield, Missouri

  • Montana Medical Research

    Missoula, Montana

  • Wake Research - Clinical Research Center of Nevada

    Las Vegas, Nevada

  • Dartmouth-Hitchcock Neurology Headache Clinic

    Lebanon, New Hampshire

  • Hassman Research Institute

    Berlin, New Jersey

  • Albuquerque Clinical Trials

    Albuquerque, New Mexico

  • SPRI Clinical Research

    Brooklyn, New York

  • Montefiore Medical Center

    The Bronx, New York

  • PharmQuest

    Greensboro, North Carolina

  • PMG Research of Wilmington

    Wilmington, North Carolina

  • CTI Clinical Research Center

    Cincinnati, Ohio

  • Rapid Medical Research

    Cleveland, Ohio

  • Neurology Diagnosis

    Dayton, Ohio

  • Delricht Research

    Tulsa, Oklahoma

  • Thomas Jefferson University/Jefferson Headache Center

    Philadelphia, Pennsylvania

  • Omega Medical Research

    Warwick, Rhode Island

  • CNS Healthcare - Memphis

    Memphis, Tennessee

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.